🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Harmony Biosciences Holdings, Inc.
Market Cap: High
Employees: Low
WAKIX
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company that develops and commercializes therapies for patients with rare neurological disorders in the United States, including its product WAKIX for the treatment of excessive daytime sleepiness in adult patients with narcolepsy.
Symbol: HRMY
Recent Price: $34.06
Industry: Biotechnology
CEO: Dr. Jeffrey M. Dayno M.D.
Sector: Healthcare
Employees: 246
Address: 630 West Germantown Pike, Plymouth Meeting, PA 19462
Phone: 484 539 9800
Leadership
- Jeffrey M. Dayno, MD, President and Chief Executive Officer
- Kumar Budur, MD, MS, Chief Medical and Scientific Officer
- Jeffrey Dierks, MBA, Chief Commercial Officer
- Sandip Kapadia, CPA, MBA, Chief Financial Officer and Chief Administrative Officer
- Christian Ulrich, General Counsel and Corporate Secretary
- Cate McCanless, Corporate Affairs and Public Policy
- Andrew Serafin, JD, MBA, Chief Strategy Officer
- Tricia Glover, Chief Compliance Officer
- Audrey Murphy, Vice President, Human Resources
- David Bradshaw, Technical Operations
- Jeffrey S. Aronin, Harmony Founder and Non-Executive Chairman Paragon Chairman and Chief Executive Officer
- Peter Anastasiou, Chief Executive Officer Capsida Biotherapeutics
- Juan Sabater, Partner Valor Equity
- Antonio Gracias, Managing Partner/Chief Investment Officer Valor Equity
- Gary Sender, Former Chief Financial Officer, Nabriva plc Independent Board Member & Consultant
- Mark Graf, Private Investor, Former Chief Financial Officer Discover Financial Services
- Linda Szyper, Former Chief Operating Officer McCann Health
- Andreas Wicki, PhD, Chief Executive Officer HBM Healthcare Investments (Cayman) Ltd
Last updated: 2024-12-31